Figure 10From: The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] Effect of simvastatin allocation on cancer incidence in participants subdivided by presenting features. Symbols and conventions as in Figures 1 & 5. Excludes non-melanoma skin cancer.Back to article page